F
FinThrive
We deliver a frictionless revenue experience—where software meets healthcare meets finance—to transform revenue management
About FinThrive
FinThrive operates in the healthcare sector, providing advanced revenue management software designed to streamline financial processes for healthcare providers, payers, and patients. The company serves a diverse range of clients within the healthcare ecosystem, including hospitals, clinics, insurance companies, and other healthcare providers. FinThrive's business model revolves around offering a comprehensive suite of revenue management solutions that integrate seamlessly to provide a 360-degree view of financial performance. This holistic approach empowers financial teams to manage revenue cycles more efficiently, reducing inefficiencies and improving financial outcomes. The company generates revenue through subscription fees for its software solutions, as well as through consulting and support services. By leveraging decades of industry experience and the combined expertise of nThrive, TransUnion Healthcare, and PELITAS, FinThrive aims to revolutionize revenue cycle management in healthcare, enabling stakeholders to focus on proactive and informed financial decision-making.
Source: Dealroom company dataAt a glance
- Founded
- 2016
- Headquarters
- Plano, United States
- Sector
- Health Tech & Medtech
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Bregal Sagemount
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about FinThrive on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See FinThrive on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.